Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall.
Published Oct 1, 2009 · K. Kajimoto, K. Miyauchi, T. Kasai
Atherosclerosis
60
Citations
0
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayAtorvastatin treatment reduces inflammation and MMP expression in abdominal aortic aneurysm walls by inhibiting JNK and dendritic cells.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.